ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 25 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,475 | -50.9% | 12,326 | -18.3% | 0.01% | -84.4% |
Q2 2023 | $39,689 | -39.0% | 15,091 | -15.5% | 0.03% | -13.5% |
Q1 2023 | $65,032 | -9.8% | 17,866 | -5.4% | 0.04% | +15.6% |
Q4 2022 | $72,073 | -15.2% | 18,887 | -7.0% | 0.03% | +14.3% |
Q3 2022 | $85,000 | -13.3% | 20,299 | -7.7% | 0.03% | +21.7% |
Q2 2022 | $98,000 | -22.2% | 22,002 | -2.1% | 0.02% | -46.5% |
Q1 2022 | $126,000 | – | 22,472 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lee Capital Holdings LLC | 11,805 | $46,482 | 0.07% |
Susquehanna International Group Ltd. | 18,887 | $72,073 | 0.03% |
Compagnie Lombard Odier SCmA | 50,000 | $190,000 | 0.01% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $50,700 | 0.00% |
OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 647 | $2,547 | 0.00% |
WELLS FARGO & COMPANY/MN | 11,746 | $46,250 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 13,499 | $52,646 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 10,420 | $40 | 0.00% |